info@targetmol.com    Tel: (857) 239-0968 / (617) 419-7131
Home > JAK
JAK
Cat.No. Product Name Information Area
T2398 Tofacitinib citrate Tofacitinib citrate (CP-690550 citrate) is a novel inhibitor of JAK3 with IC50 of 1 n... Cancer
T2360 Baricitinib phosphate Baricitinib phosphate(INCB 028050; LY 3009104) is a selective JAK1 and JAK2 inhibitor... Cancer
T2349 BMS-754807 BMS-754807 is a potent and reversible inhibitor of IGF-1R/InsR with IC50 of 1.8 nM/1.... Cancer
T2156 WP1066 WP1066 is a novel inhibitor of JAK2 and STAT3 with IC50 of 2.30 μM and 2.43 μM in HEL... Cancer
T2045 WHI-P131 Janex-1 is a cell-permeable, reversible, potent, ATP-competitive, and specific inhibi... Other
T2012 Oclacitinib Oclacitinib(PF03394197) is a potent and selective JAKs inhibitor with IC50 of 10-99 n... Other
T1995 Fedratinib (SAR302503, TG101348) Fedratinib (SAR302503, TG101348) is a selective inhibitor of JAK2 with IC50 of 3 nM i... Other
T1985 WHI-P154 WHI-P154 is a potent JAK3 inhibitor with IC50 of 1.8 μM, no activity against JAK1 or ... Other
T1929 Filgotinib (GLPG0634) GLPG0634(filgotinib) is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM,... Other
T1849 CYT387 CYT387(momelotinib) is an ATP-competitive inhibitor of JAK1/JAK2 with IC50 of 11 nM/1... Other
T1829 Ruxolitinibhot Ruxolitinib(INCB018424) is the first potent, selective, JAK1/2 inhibitor to enter the... Cardiovascular System
T6321 Tofacitinib Tofacitinib (CP-690550,Tasocitinib) is a novel inhibitor of JAK3 with IC50 of 1 nM, 2... Cancer
T6309 AZ 960 AZ 960 is a novel ATP competitive JAK2 inhibitor with IC50 and Ki of <3 nM and 0.45 n... Cancer
T6294 NVP-BSK805 diHydrochloride NVP-BSK805 2HCl is a potent and selective ATP-competitive JAK2 inhibitor with IC50 of... Cancer
2